Code is for vertebral compression fracture detection with CT scans.
Zebra Medical Vision announced July 7 it has received approval of its CPT application for using artificial intelligence (AI) with CT scans to detect vertebral compression fractures (VCF) from the American Medical Association (AMA).
This is the first AI CPT code specific to radiology.
“The latest development regarding the CPT code approval by the AMA is an industry milestone in the effort to boost the adoption of AI in imaging for VCFs and other under-diagnosed chronic conditions for which can help reveal and drive care,” said Zohar Elhanani, Zebra Medical Vision chief executive officer. “Radiologists will now be able to identify more patients with undiagnosed fractures and provide better care for patients who may be vulnerable.”
Osteoporotic fractures affect nearly 50 percent of men and 25 percent of women during their lifetimes, resulting in 2 million broken bones annually and an estimated $52 billion cost to the U.S. healthcare system. Still, Zebra Medical officials said, 75 percent of these fractures go undetected.
According to existing data, Zebra Medical’s VCF solution can increase detection rates, bringing needed treatment to more patients without addition imaging or radiation. With this CPT code in place, providers using the tool will be able to submit for reimbursement, potentially increasing its use.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.